Literature DB >> 34849654

Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.

Can Li1, Yanxia Chen1, Yan Zhao1, David Christopher Lung2, Zhanhong Ye1, Wenchen Song1, Fei-Fei Liu1, Jian-Piao Cai1, Wan-Man Wong1, Cyril Chik-YanYip1, Jasper Fuk-Woo Chan1,3,4, Kelvin Kai-Wang To1,3, Siddharth Sridhar1,3, Ivan Fan-Ngai Hung3,5, Hin Chu1, Kin-Hang Kok1, Dong-Yan Jin6, Anna JinxiaZhang1, Kwok-Yung Yuen1,3,4.   

Abstract

Entities:  

Year:  2021        PMID: 34849654      PMCID: PMC8690168          DOI: 10.1093/cid/ciab941

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
After the original publication of this manuscript [Li C, Chen Y, Zhao Y et al. Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model. Clin Infect Dis, August 2021. https://doi.org/10.1093/cid/ciab707], it was discovered that Figure 5C on the TUNEL staining for apoptotic changes was mistakenly taken from another group of mice. This does not affect the findings for this manuscript, and a revised figure is available in the version currently online. The statement ‘Serum troponin level was significantly higher in IV group.’ has also been inserted into the Results section of the abstract.
  6 in total

1.  Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model.

Authors:  Yanxia Chen; Can Li; Feifei Liu; Zhanhong Ye; Wenchen Song; Andrew C Y Lee; Huiping Shuai; Lu Lu; Kelvin Kai-Wang To; Jasper Fuk-Woo Chan; Anna Jinxia Zhang; Hin Chu; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

2.  A Small but Significantly Greater Incidence of Inflammatory Heart Disease Identified After Vaccination for Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Kirk U Knowlton; Stacey Knight; Joseph B Muhlestein; Viet T Le; Benjamin D Horne; Heidi T May; Edward A Stenehjem; Jeffrey L Anderson
Journal:  Open Forum Infect Dis       Date:  2021-12-30       Impact factor: 3.835

3.  The potential rationale of COVID-19 vaccine-induced myopericarditis.

Authors:  Tsz Yuen Au; Chanika Assavarittirong
Journal:  J Med Virol       Date:  2022-06-11       Impact factor: 20.693

4.  Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series.

Authors:  Christian Baumeier; Ganna Aleshcheva; Dominik Harms; Ulrich Gross; Christian Hamm; Birgit Assmus; Ralf Westenfeld; Malte Kelm; Spyros Rammos; Philip Wenzel; Thomas Münzel; Albrecht Elsässer; Mudather Gailani; Christian Perings; Alae Bourakkadi; Markus Flesch; Tibor Kempf; Johann Bauersachs; Felicitas Escher; Heinz-Peter Schultheiss
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

Review 5.  Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy.

Authors:  Chi Zhang; Yifan Ma; Jingjing Zhang; Jimmy Chun-Tien Kuo; Zhongkun Zhang; Haotian Xie; Jing Zhu; Tongzheng Liu
Journal:  Molecules       Date:  2022-03-17       Impact factor: 4.411

Review 6.  To aspirate or not to aspirate? Considerations for the COVID-19 vaccines.

Authors:  Piotr Rzymski; Andrzej Fal
Journal:  Pharmacol Rep       Date:  2022-03-23       Impact factor: 3.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.